Literature DB >> 24481938

An indeterminate result of QuantiFERON-TB Gold In-Tube for miliary tuberculosis due to a high level of IFN-γ production.

Sho Hangai1, Akihide Yoshimi, Atsuko Hosoi, Keisuke Matsusaka, Motoshi Ichikawa, Masashi Fukayama, Mineo Kurokawa.   

Abstract

The QuantiFERON-TB Gold In-Tube(®) test has excellent specificity for Mycobacterium tuberculosis. However, diagnosis of miliary tuberculosis remains challenging, and the interpretation of QuantiFERON(®) results in immunocompromised individuals has not been fully established. Here, we present a patient with military tuberculosis who showed an indeterminate QuantiFERON(®) result. A 76-year-old male presented with fever and pancytopenia. Radiological tests did not show the classical miliary pattern. Acid-fast staining and polymerase chain reaction of several specimens were negative for M. tuberculosis. The QuantiFERON(®) responses were indeterminate on two separate tests, as interferon-γ (IFN-γ) concentration was high in the negative control. The patient did not respond to anti-microbiological therapy, and developed sepsis and disseminated intravascular coagulation, leading to lethal intracranial hemorrhage. An autopsy showed miliary tuberculosis and aplastic anemia. A literature review suggests a tendency towards indeterminate or false-negative QuantiFERON(®) results in immunocompromised individuals or patients with miliary tuberculosis due to low production of IFN-γ. Our patient, however, showed substantial amounts of IFN-γ despite lymphocytopenia, which has not been reported in the literature. The present case suggests that indeterminate results of QuantiFERON(®) should be interpreted with caution, as IFN-γ production in patients with miliary tuberculosis can vary significantly, even with sustained lymphocytopenia.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24481938     DOI: 10.1007/s12185-014-1504-3

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  Diagnostic accuracy of Quantiferon TB test for patients with SLE and miliary tuberculosis.

Authors:  Mukaddes Tozlu; Umut Kalyoncu; Sehnaz Alp; Serhat Unal; Meral Calguneri
Journal:  Rheumatol Int       Date:  2009-06-04       Impact factor: 2.631

3.  Sensitivity analysis and potential uses of a novel gamma interferon release assay for diagnosis of tuberculosis.

Authors:  Simon J Tsiouris; David Coetzee; Patricia L Toro; Judy Austin; Zena Stein; Wafaa El-Sadr
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 4.  Miliary tuberculosis: new insights into an old disease.

Authors:  Surendra Kumar Sharma; Alladi Mohan; Anju Sharma; Dipendra Kumar Mitra
Journal:  Lancet Infect Dis       Date:  2005-07       Impact factor: 25.071

5.  Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research.

Authors:  Dick Menzies; Madhukar Pai; George Comstock
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

6.  Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens.

Authors:  Sung-Hoon Jung; Soo-Young Bae; Jae-Sook Ahn; Seung-Ji Kang; Deok-Hwan Yang; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Int J Hematol       Date:  2013-01-25       Impact factor: 2.490

7.  An indeterminate QuantiFERON TB-2G response for miliary tuberculosis, due to severe pancytopenia.

Authors:  Yoshihiro Kobashi; Minoru Fukuda; Kouichiro Yoshida; Mikio Oka
Journal:  J Infect Chemother       Date:  2007-12-25       Impact factor: 2.211

8.  Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals.

Authors:  Maximilian C Aichelburg; Armin Rieger; Florian Breitenecker; Katharina Pfistershammer; Julia Tittes; Stephanie Eltz; Alexander C Aichelburg; Georg Stingl; Athanasios Makristathis; Norbert Kohrgruber
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

9.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

10.  The effects of HIV on the sensitivity of a whole blood IFN-gamma release assay in Zambian adults with active tuberculosis.

Authors:  Edward Raby; Maureen Moyo; Akash Devendra; Joseph Banda; Petra De Haas; Helen Ayles; Peter Godfrey-Faussett
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  10 in total
  3 in total

1.  IFN-γ Release Assay Result Is Associated with Disease Site and Death in Active Tuberculosis.

Authors:  Sara C Auld; Scott H Lee; Eleanor S Click; Roque Miramontes; Cheryl L Day; Neel R Gandhi; Charles M Heilig
Journal:  Ann Am Thorac Soc       Date:  2016-12

2.  Alternative Quantiferon cytokines for diagnosis of children with active tuberculosis and HIV co-infection in Ghana.

Authors:  Christian Lundtoft; Anthony Afum-Adjei Awuah; Norman Nausch; Anthony Enimil; Ertan Mayatepek; Ellis Owusu-Dabo; Marc Jacobsen
Journal:  Med Microbiol Immunol       Date:  2017-03-15       Impact factor: 3.402

3.  Features of indeterminate results of QuantiFERON-TB Gold In-Tube test in patients with haematological malignancies.

Authors:  Chen-Cheng Huang; Chieh-Lin Jerry Teng; Ming-Feng Wu; Ching-Hsiao Lee; Hui-Chen Chen; Wei-Chang Huang
Journal:  Ther Adv Hematol       Date:  2021-07-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.